Cargando…
Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
Cancer cells have a very different metabolism from that of normal cells from which they are derived. Their metabolism is elevated, which allows them to sustain higher proliferative rate and resist some cell death signals. This phenomenon, known as the “Warburg effect”, has become the focus of intens...
Autores principales: | Akins, Nicholas S., Nielson, Tanner C., Le, Hoang V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110043/ https://www.ncbi.nlm.nih.gov/pubmed/29788892 http://dx.doi.org/10.2174/1568026618666180523111351 |
Ejemplares similares
-
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
por: Ahmed, Shanzay, et al.
Publicado: (2023) -
Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
por: Sun, Li, et al.
Publicado: (2017) -
Glutaminolysis and Glycolysis Are Essential for Optimal Replication of Marek’s Disease Virus
por: Boodhoo, Nitish, et al.
Publicado: (2020) -
Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2(+/−) Mice()
por: Jones, Ashley T., et al.
Publicado: (2019) -
Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells
por: Kao, Ting-Wan, et al.
Publicado: (2022)